DAIICHI SANKYO CHEMICAL PHARMA CO

Company Introduction for DAIICHI SANKYO CHEMICAL PHARMA CO

DAIICHI SANKYO CHEMICAL PHARMA CO is a global pharmaceutical company with its primary headquarters in Japan. The company is dedicated to the comprehensive process of research, development, manufacturing, and marketing of innovative pharmaceutical products. It focuses on addressing various medical needs, particularly in therapeutic areas such as oncology, cardiovascular diseases, and infectious diseases, aiming to improve patient health worldwide.

Belongs to Factory or Trader:

DAIICHI SANKYO CHEMICAL PHARMA CO is fundamentally a manufacturing company (Factory).

Regarding its operations specifically in India:

Globally, Daiichi Sankyo is a major pharmaceutical manufacturer. Historically, the company had a significant manufacturing footprint in India through its acquisition of Ranbaxy Laboratories. However, following the divestment of Ranbaxy to Sun Pharma in 2014, Daiichi Sankyo's direct, large-scale manufacturing facilities under its own name in India have ceased. Its current activities in India are primarily focused on commercial operations, including sales, marketing, and distribution of its pharmaceutical products, alongside clinical research.

Based on available information, DAIICHI SANKYO CHEMICAL PHARMA INDIA primarily manufactures and sells Active Pharmaceutical Ingredients (APIs). The specific APIs produced are not publicly detailed in a comprehensive list.

DAIICHI SANKYO CHEMICAL PHARMA INDIA mainly focuses on:

* **APIs (Active Pharmaceutical Ingredients)**